CRP and bone neoplasm: The random effects model showed a significant relationship between elevated levels of CRP and OS in patients with bone neoplasms (HR: 1.87; 95% CI: 1.28–2.75; P = 0.001), with heterogeneity (I2 = 62.4%, P = 0.031, Fig 2).